1-12 of 12
Richard A. Walgren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor

Eliana B. Gomez, Kevin Ebata, Hetal S. Randeria, Mary S. Rosendahl, E. Peder Cedervall, Tony H. Morales, Lauren M. Hanson, Nicholas E. Brown, Xueqian Gong, Jennifer Stephens, Wenjuan Wu, Isabel Lippincott, Karin S. Ku, Richard A. Walgren, Paolo B. Abada, Joshua A. Ballard, Charles K. Allerston, Barbara J. Brandhuber
Journal: Blood
Blood (2023) 142 (1): 62–72.
https://doi.org/10.1182/blood.2022018674
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and Tolerability of Pirtobrutinib Monotherapy in Patients with B-Cell Malignancies Who Were Previously Intolerant to a Covalent BTK Inhibitor: Results from the Phase 1/2 BRUIN Study

Nirav N. Shah, Michael L. Wang, Jennifer R. Brown, Krish Patel, Jennifer A. Woyach, William G. Wierda, Chaitra S. Ujjani, Toby A. Eyre, Pier Luigi Zinzani, Alvaro J. Alencar, Thomas Gastinne, Paolo Ghia, Nicole Lamanna, Marc Hoffmann, Manish R. Patel, Ian W. Flinn, James N. Gerson, Shuo Ma, Catherine C. Coombs, Chan Y. Cheah, Ewa Lech-Marańda, Bita Fakhri, Won-Seog Kim, Minal A. Barve, Jonathon B. Cohen, Wojciech Jurczak, Talha Munir, Meghan C. Thompson, Lindsey E. Roeker, Katherine Bao, Nicholas A. Cangemi, Jennifer F. Kherani, Richard A. Walgren, Hongmei Han, Amy S. Ruppert, Anthony R. Mato
Journal: Blood
Blood (2022) 140 (Supplement 1): 4127–4132.
https://doi.org/10.1182/blood-2022-159035
Published: 2022
Journal Articles

Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study

Michael L. Wang, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian W. Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, Ewa Lech-Marańda, Joanna M. Rhodes, Krish Patel, Jennifer A. Woyach, Nicole Lamanna, Yucai Wang, Constantine S. Tam, John F. Seymour, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Andrew D. Zelenetz, Preetesh Jain, Binoj Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo B. Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato
Journal: Blood
Blood (2022) 140 (Supplement 1): 9368–9372.
https://doi.org/10.1182/blood-2022-159425
Published: 2022
Journal Articles

Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Waldenström Macroglobulinemia: Results from the Phase 1/2 BRUIN Study

M.Lia Palomba, Manish R. Patel, Toby A. Eyre, Wojciech Jurczak, David John Lewis, Thomas Gastinne, Shuo Ma, Jonathon B. Cohen, Krish Patel, Jennifer R. Brown, Lydia Scarfò, Talha Munir, Ewa Lech-Marańda, Marc Hoffmann, Chaitra S. Ujjani, Bita Fakhri, Michael L. Wang, Koji Izutsu, Hirokazu Nagai, Constantine S. Tam, John F. Seymour, Joanna M. Rhodes, Julie M. Vose, Matthew McKinney, James N. Gerson, Minal A. Barve, Bryone J. Kuss, Youngil Koh, Wei Gao, Amy S. Ruppert, Richard A. Walgren, Donald E. Tsai, Binoj Nair, Katherine Bao, Anthony R. Mato, Chan Y. Cheah
Journal: Blood
Blood (2022) 140 (Supplement 1): 557–560.
https://doi.org/10.1182/blood-2022-159123
Published: 2022
Journal Articles

Outcomes for Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States and Japan: A Study of Two Real-World Databases

Shinya Rai, Lisa M. Hess, Yongmei Chen, Lee Bowman, Paolo B. Abada, Heiko Konig, Richard A. Walgren, Yoshinori Tanizawa, Zhihong Cai, Masaomi Tajimi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4523.
https://doi.org/10.1182/blood-2021-148265
Published: 2021
Journal Articles

Comorbidity Burden in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Keith L Davis, MA, Gregory L Price, MPH, Sudeep Karve, PhD, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1734.
https://doi.org/10.1182/blood.V120.21.1734.1734
Published: 2012
Journal Articles

Health Care Utilization and Associated Costs in Elderly Persons with Non-CML Myeloproliferative Neoplasms: Real-World Evidence From a United States Medicare Population

Sudeep Karve, PhD, Gregory L Price, MPH, Keith L Davis, MA, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4273.
https://doi.org/10.1182/blood.V120.21.4273.4273
Published: 2012
Journal Articles

Survival Patterns in Patients with Non-CML Myeloproliferative Neoplasms: Evidence From a United States SEER/Medicare Population

Gregory L. Price, MPH, Keith L Davis, MA, Sudeep Karve, PhD, Gerhardt M Pohl, PhD, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 428.
https://doi.org/10.1182/blood.V120.21.428.428
Published: 2012
Journal Articles

Phase I Study of the JAK2 V617F Inhibitor, LY2784544, in Patients with Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Susanne Kloeker Rhoades, PhD, Jennifer L K Giles, BSc, Celine Pitou, PharmD, Emma Jones, PhD, Richard A Walgren, MD, PhD, Josef T. Prchal, MD
Journal: Blood
Blood (2011) 118 (21): 2814.
https://doi.org/10.1182/blood.V118.21.2814.2814
Published: 2011
Journal Articles

A Retrospective Observational Comparison of Comorbidities Between Myeloproliferative Neoplasm (MPN) Patients and Matched Controls in a Commercially Insured US Population

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3140.
https://doi.org/10.1182/blood.V118.21.3140.3140
Published: 2011
Journal Articles

A Retrospective Observational Study of Annual Healthcare Costs for Patients with Forms of Myeloproliferative Neoplasms (MPN)

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2060.
https://doi.org/10.1182/blood.V118.21.2060.2060
Published: 2011
Journal Articles

Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility

Jeffrey A. Knight, Andrew D. Skol, Abhijit Shinde, Darcie Hastings, Richard A. Walgren, Jin Shao, Thelma R. Tennant, Mekhala Banerjee, James M. Allan, Michelle M. Le Beau, Richard A. Larson, Timothy A. Graubert, Nancy J. Cox, Kenan Onel
Journal: Blood
Blood (2009) 113 (22): 5575–5582.
https://doi.org/10.1182/blood-2008-10-183244
Published: 2009
Includes: Supplemental data